These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8266793)

  • 1. Mucosal exudation of fibrinogen in coronavirus-induced common colds.
    Akerlund A; Greiff L; Andersson M; Bende M; Alkner U; Persson CG
    Acta Otolaryngol; 1993 Sep; 113(5):642-8. PubMed ID: 8266793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microvascular exudative hyperresponsiveness in human coronavirus-induced common cold.
    Greiff L; Andersson M; Akerlund A; Wollmer P; Svensson C; Alkner U; Persson CG
    Thorax; 1994 Feb; 49(2):121-7. PubMed ID: 8128400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nasal cytokines in common cold and allergic rhinitis.
    Linden M; Greiff L; Andersson M; Svensson C; Akerlund A; Bende M; Andersson E; Persson CG
    Clin Exp Allergy; 1995 Feb; 25(2):166-72. PubMed ID: 7750009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical nitroprusside may reduce histamine-induced plasma exudation in human nasal airways.
    Greiff L; Andersson M; Svensson C; Nilsson M; Erjefält I; Erjefält JS; Persson CG
    Allergy; 1995 Jul; 50(7):593-7. PubMed ID: 8588693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nasal mucosal endorgan hyperresponsiveness.
    Svensson C; Andersson M; Greiff L; Persson CG
    Am J Rhinol; 1998; 12(1):37-43. PubMed ID: 9513658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of two weeks of topical budesonide treatment on microvascular exudative responsiveness in healthy human nasal airways.
    Greiff L; Andersson M; Svensson C; Akerlund A; Alkner U; Persson CG
    Eur Respir J; 1997 Apr; 10(4):841-5. PubMed ID: 9150322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nasal neutrophil activity and mucinous secretory responsiveness in COPD.
    Nihlén U; Andersson M; Löfdahl CG; Persson CG; Montnémery P; Greiff L
    Clin Physiol Funct Imaging; 2003 May; 23(3):138-42. PubMed ID: 12752555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histamine-induced airway mucosal exudation of bulk plasma and plasma-derived mediators is not inhibited by intravenous bronchodilators.
    Svensson C; Alkner U; Pipkorn U; Persson CG
    Eur J Clin Pharmacol; 1994; 46(1):59-65. PubMed ID: 8005188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of experimental changes in nasal airway pressure on mucosal output of plasma.
    Berg S; Wollmer P; Andersson M; Persson CG; Greiff L
    Clin Physiol Funct Imaging; 2003 May; 23(3):155-8. PubMed ID: 12752558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The "nasal pool"-device for challenge and lavage of the nasal mucosa in children: histamine-induced plasma exudation responses.
    Greiff L; Meyer P; Svensson C; Persson CG; Andersson M
    Pediatr Allergy Immunol; 1997 Aug; 8(3):137-42. PubMed ID: 9532254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-linked fibrin in the nasal fluid of patients with the common cold.
    Winther B; Gwaltney JM; Humphries JE; Hendley JO
    Clin Infect Dis; 2002 Mar; 34(5):708-10. PubMed ID: 11823958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Olfactory threshold and nasal mucosal changes in experimentally induced common cold.
    Akerlund A; Bende M; Murphy C
    Acta Otolaryngol; 1995 Jan; 115(1):88-92. PubMed ID: 7762392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Day-night differences in mucosal plasma proteins in common cold.
    Greiff L; Akerlund A; Andersson M; Svensson C; Alkner U; Persson CG
    Acta Otolaryngol; 1996 Jan; 116(1):85-90. PubMed ID: 8820357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenge-induced plasma exudation and mucinous secretion in human airways.
    Greiff L; Andersson M; Coman WB; Lindberg H; Marko-Varga G; Wallwork B; Persson CG
    Clin Physiol Funct Imaging; 2005 Jul; 25(4):241-5. PubMed ID: 15972027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical vasoconstrictor (oxymetazoline) does not affect histamine-induced mucosal exudation of plasma in human nasal airways.
    Svensson C; Pipkorn U; Alkner U; Baumgarten CR; Persson CG
    Clin Exp Allergy; 1992 Mar; 22(3):411-6. PubMed ID: 1586878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of nasal barrier dysfunction at acute- and late-phase reactions in a guinea pig model of allergic rhinitis.
    Elovsson S; Smailagic A; Erjefalt I; Zackrisson C; Eriksson C; Wang X
    Vascul Pharmacol; 2005 Oct; 43(4):267-76. PubMed ID: 16257271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Onset of action of a topical antihistamine as assessed by histamine challenge-induced plasma exudation responses.
    Korsgren M; Andersson M; Larsson L; Aldén-Raboisson M; Greiff L
    Ann Allergy Asthma Immunol; 2006 Feb; 96(2):345-8. PubMed ID: 16498858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversibility and reproducibility of histamine induced plasma leakage in nasal airways.
    Svensson C; Baumgarten CR; Pipkorn U; Alkner U; Persson CG
    Thorax; 1989 Jan; 44(1):13-8. PubMed ID: 2648641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of allergic inflammation of the nasal mucosa on the severity of rhinovirus 16 cold.
    Avila PC; Abisheganaden JA; Wong H; Liu J; Yagi S; Schnurr D; Kishiyama JL; Boushey HA
    J Allergy Clin Immunol; 2000 May; 105(5):923-32. PubMed ID: 10808173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in human nasal mucosa during experimental coronavirus common colds.
    Bende M; Barrow I; Heptonstall J; Higgins PG; Al-Nakib W; Tyrrell DA; Akerlund A
    Acta Otolaryngol; 1989; 107(3-4):262-9. PubMed ID: 2538995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.